Actavis plc (ACT)

Index: S&P 100
-1.13%
-$2.82
$246.23
21:26 27/06/17
$246.23
21:26 27/06/17
DAILY VARIATION
-1.13%
-$2.82
VOLUME
1,628,057
DATA
52 Week High
$260.24
52 Week Low
$188.47
Shares Issued
335.50m
Market Cap
$82,609.26m
RiskGrade
n/a
Beta
0.85
MENU

Actavis plc Overview

Founded in 1984, Watson Pharmaceuticals is a leading specialty pharmaceutical company that develops, manufactures and markets brand and generic pharmaceutical products. It utilises various drug delivery technologies, such as solid dosage form, oral controlled release, transdermal, and oral transmucosal delivery systems. Watson currently markets numerous brand product lines, several of which hold leading market positions. At the end of 2002, California-based Watson marketed over 30 branded pharmaceutical products and approximately 130 generic pharmaceutical products.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 1.0%
Div Cover n/a 6.4
Op Mrgn -12.5% 41.7%
ROCE 51,468.1%
Latest F'cast
P/E -77.6 1,531.8
PEG 0.0 -999,999.0
Pr/Revenue 5.7 5.2
Pr/Book 1.1
Latest F'cast
Revenue 14.8% -13.2%
PBT 0.0% n/a
EPS 0.0% -7.4%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 5,914.90 245.10 77.00¢ 111.7 -1.8 -63% n/a 0.0%
2013-12-31 8,677.60 -638.40 -527.00¢ -31.9 0.0 n/a n/a 0.0%
2014-12-31 6,738.90 -2,874.10 -742.00¢ -34.7 0.0 n/a n/a 0.0%
2015-12-31 12,688.10 -4,547.50 -864.00¢ -36.2 0.0 n/a n/a 0.0%
2016-12-31 14,570.60 -2,832.00 -317.00¢ -66.2 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 15,780.25 6,575.07 1,608.79c 1,531.8 n/a 0% 251.42c 1.0%
2018-12-31 16,921.58 7,346.83 1,793.69c 1,373.1 119.5 11% 262.99c 1.1%

Regulatory News

No results found

Newspaper Links

No results found